View Older Stories

Jan 12, 2026 01:46PM Soleno Therapeutics Inc. (SLNO) PT Lowered to $60 at Wolfe, 'We think the stock reaction reflects the focus around new pt starts'

Jan 12, 2026 08:50AM Stifel on Soleno Therapeutics (SLNO): 'We think SLNO's pre-print is overall solid'

Jan 12, 2026 07:03AM Soleno Therapeutics reports preliminary 2025 revenue of up to $191 million

Jan 5, 2026 08:01AM Soleno Therapeutics publishes VYKAT XR study results in medical journal

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Nov 17, 2025 04:14PM Wolfe Research Starts Soleno Therapeutics Inc. (SLNO) at Outperform

Nov 4, 2025 04:23PM Soleno Therapeutics, Inc. (SLNO) Tops Q3 EPS by 42c

Oct 7, 2025 02:49AM Goldman Sachs Starts Soleno Therapeutics Inc. (SLNO) at Buy

Oct 3, 2025 08:21AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'Why We Remain Bullish on VYKAT XR Launch'

Oct 1, 2025 07:24AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $115 at Stifel

Sep 25, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Sep 25, 2025 04:09AM Baird on Soleno Therapeutics Inc. (SLNO): 'a favorable buying opportunity'

Sep 24, 2025 09:29AM Baird: 'Acadia shares should come out relatively unscathed after the dust settles'

Sep 24, 2025 08:26AM ACAD failure eliminates a competitive threat to Soleno Therapeutics (SLNO) - Oppenheimer

Sep 24, 2025 08:05AM BMO Capital: 'expect ACAD shares to decline'

Sep 24, 2025 07:53AM Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'

Sep 24, 2025 07:34AM Stifel on Soleno Therapeutics Inc. (SLNO): 'we remain bullish and believe Vykat is well-positioned for significant/sustained growth'

Sep 11, 2025 08:27AM TD Cowen Reiterates Buy on Soleno Therapeutics (SLNO) as Vykat XR Launch Has Exceeds Expectations

Sep 11, 2025 06:59AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Sep 10, 2025 02:03PM Baird Defends Soleno Therapeutics Inc. (SLNO): 'Selloff on Likely Unrelated Patient Death Strengthens Buying Opportunity'

Sep 10, 2025 01:46PM TD Cowen on Soleno Therapeutics Inc. (SLNO): 'Patient Death Not Treatment Related; Vykat XR Safety Continues To Be Consistent'

Sep 10, 2025 12:36PM Soleno Therapeutics reports death of patient taking VYKAT XR drug

Sep 10, 2025 11:25AM Soleno Therapeutics (SLNO) Falls 17%

Aug 21, 2025 11:19AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'Strong Launch Execution Could Lift Shares'

Aug 20, 2025 05:28AM Wells Fargo Starts Soleno Therapeutics Inc. (SLNO) at Overweight

Aug 19, 2025 10:24AM Scorpion Capital Still Short Soleno Therapeutics (SLNO)

Aug 19, 2025 06:54AM Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)

Aug 19, 2025 05:12AM Baird on Soleno Therapeutics Inc. (SLNO): 'Buyers on pullback following short report'

Aug 18, 2025 09:39AM TD Cowen Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Aug 18, 2025 06:47AM Soleno Therapeutics Inc. (SLNO) PT Raised to $110 at H.C. Wainwright

Aug 15, 2025 09:21AM Soleno Therapeutics (SLNO) Mentioned as Short at Scorpion Capital

Aug 7, 2025 10:07AM Soleno Therapeutics Inc. (SLNO) PT Raised to $118 at Stifel

Aug 7, 2025 06:56AM Soleno Therapeutics Inc. (SLNO) PT Raised to $106 at Guggenheim

Aug 6, 2025 04:12PM Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 55c

Aug 6, 2025 04:04PM Soleno Therapeutics reports early commercial traction for VYKAT XR

Aug 6, 2025 04:15AM Rhythm Pharmaceuticals (RYTM) PT Raised to $135 at Citizens JMP

Jul 11, 2025 07:26AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Jul 10, 2025 04:13PM Soleno Therapeutics Inc. (SLNO) PT Raised to $121 at Baird

Jul 10, 2025 09:08AM Soleno Therapeutics prices $200 million stock offering at $85 per share

Jul 10, 2025 07:24AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Jul 10, 2025 06:01AM Soleno Therapeutics reports preliminary Q2 revenue of $31-33 million

Jul 8, 2025 07:05AM Stifel Raises PT to $115 on Soleno Therapeutics Inc. (SLNO)

Jul 7, 2025 04:27PM Soleno Therapeutics Inc. (SLNO) PT Raised to $115 at Stifel

Jul 7, 2025 09:41AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'VYKAT XR PWS Launch Is Destined for Success'

Jun 25, 2025 08:02AM Soleno Therapeutics (SLNO) Highlights New Data on VYKAT(TM) XR

Jun 23, 2025 05:31AM TD Cowen Starts Soleno Therapeutics Inc. (SLNO) at Buy

Jun 17, 2025 08:07AM Piper Sandler 'Remains Bullish' on Soleno Therapeutics Inc. (SLNO)

May 27, 2025 09:52AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

May 22, 2025 05:35PM Soleno Therapeutics (SLNO) announces EMA validation of MAA

May 22, 2025 07:32AM Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)

View Older Stories